AR004677A1 - Derivados de la 4-sulfonilbenzoilguanidina o 4-sulfinilbenzoilguanidina, procedimiento para prepararlos y composiciones farmaceuticas que los contienen - Google Patents
Derivados de la 4-sulfonilbenzoilguanidina o 4-sulfinilbenzoilguanidina, procedimiento para prepararlos y composiciones farmaceuticas que los contienenInfo
- Publication number
- AR004677A1 AR004677A1 ARP960103933A AR10393396A AR004677A1 AR 004677 A1 AR004677 A1 AR 004677A1 AR P960103933 A ARP960103933 A AR P960103933A AR 10393396 A AR10393396 A AR 10393396A AR 004677 A1 AR004677 A1 AR 004677A1
- Authority
- AR
- Argentina
- Prior art keywords
- hal
- carbon atoms
- preparing
- ch2f
- chf2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Leads Or Probes (AREA)
Abstract
El invento se referie a las 4-sulfonilbenzoilguanidinas o 4- sulfinil benzoilguanidinas de fórmula (I), en la que R1 es A, CF3, CH2F, CHF2, C2F5, CN,NO2 o Hal, R2 es -SOnR6, -SO2NR4R5, NO2, ó CF3; R3es H, Hal, A, OH, OA, CN, NO2, CF3,CH2F, CHF2, C2F5 ó CH2CF3; R4 y R5 son independientemente H, A,cicloalquilo de 5 a 7 átomos de C, cicloalquilmetilo de 4 a 8 átomos de C, Ph ó -CH2-Ph; o bien R4 y R5 son juntos alquileno de 4 a 5 átomos de C, en dondeun grupo CH2 también puedeser reem plazado por O, S, NH, N-A ó N-CH2-Ph; R6 es A, PH, Het o cicloalquilo (C3-7), Het representa un heterociclo de uno o dosnúcleos, saturado, insaturado o aromático, con 1 a 4 átomos de N, O y/o S, unido a través del N ó C, que puedeestar no sust ituido o sustituido una, dos otres veces con Hal, SH, SA, NH2, NHA, NA2, CF3, A, OH, OA, CN, NO2, y/o carboniloxi; A es alquilo de 1 a 6 átomos de C; Hal es F, Cl, Br ó I; Phes fenilo no sustituido o sustituido una, dos o tresveces con A, OA , NR4R5, F, Cl, Br, I ó CF3 y n es 1 ó 2; y sus sales aceptables desde el punto devista fisiológico. También se refiere a un procedimiento para preparar dichos compuestos, a preparaciones farmacéuticas que los contienen y alempleo de losmismos para el tratamiento de las arritmias, de la angina de pecho, infartos y también para el tratamiento preventivo de estas enfermedades. Los nuevoscompuestos del invento poseen propiedades antiarrítmicas y un efecto inhibidor delmecanismo de intercam bio de Na+/H+ de la células
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19529612A DE19529612A1 (de) | 1995-08-11 | 1995-08-11 | Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
AR004677A1 true AR004677A1 (es) | 1999-03-10 |
Family
ID=7769293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960103933A AR004677A1 (es) | 1995-08-11 | 1996-08-09 | Derivados de la 4-sulfonilbenzoilguanidina o 4-sulfinilbenzoilguanidina, procedimiento para prepararlos y composiciones farmaceuticas que los contienen |
Country Status (25)
Country | Link |
---|---|
US (1) | US5744641A (es) |
EP (1) | EP0758644B1 (es) |
JP (1) | JP3901766B2 (es) |
KR (1) | KR100447111B1 (es) |
CN (1) | CN1071743C (es) |
AR (1) | AR004677A1 (es) |
AT (1) | ATE252075T1 (es) |
AU (1) | AU709800B2 (es) |
BR (1) | BR9603377B1 (es) |
CA (1) | CA2183050C (es) |
CZ (1) | CZ292974B6 (es) |
DE (2) | DE19529612A1 (es) |
DK (1) | DK0758644T3 (es) |
ES (1) | ES2206534T3 (es) |
HU (1) | HU226134B1 (es) |
MX (1) | MX9603300A (es) |
NO (1) | NO306858B1 (es) |
PL (1) | PL184320B1 (es) |
PT (1) | PT758644E (es) |
RU (1) | RU2159232C2 (es) |
SI (1) | SI0758644T1 (es) |
SK (1) | SK281661B6 (es) |
TW (1) | TW432039B (es) |
UA (1) | UA45965C2 (es) |
ZA (1) | ZA966773B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4328352A1 (de) * | 1993-08-24 | 1995-03-02 | Hoechst Ag | Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19833118C2 (de) | 1998-07-23 | 2000-07-27 | Merck Patent Gmbh | Verfahren zur Herstellung von orthoalkylierten Benzoesäurederivaten |
DE19903275A1 (de) * | 1999-01-28 | 2000-08-03 | Merck Patent Gmbh | Lyophilisate mit verbesserter Rekonstituierbarkeit |
DE19951418A1 (de) * | 1999-10-26 | 2001-05-03 | Merck Patent Gmbh | Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid |
DE10001879A1 (de) | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE10023405A1 (de) | 2000-05-12 | 2001-11-15 | Merck Patent Gmbh | Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen |
KR100643561B1 (ko) * | 2000-12-08 | 2006-11-10 | 엘지.필립스 엘시디 주식회사 | 액정표시장치용 어레이기판과 어레이기판의 제조방법 |
DE10305070A1 (de) * | 2003-02-07 | 2004-08-26 | Merck Patent Gmbh | Verwendung von N-(4,5-Methansulfonyl-2-methyl-benzoyl)-guanidin |
BRPI0410022A (pt) * | 2003-05-06 | 2006-04-25 | Merck Patent Gmbh | processo para a cristalização de sais de guanidìnio |
DE102004045825A1 (de) * | 2004-09-22 | 2006-03-23 | Merck Patent Gmbh | Lyophilisat enthaltend N-Diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid |
US20110060051A1 (en) | 2008-05-09 | 2011-03-10 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction |
EP2342178B1 (en) | 2008-09-02 | 2016-09-28 | Sanofi | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
FR2948028B1 (fr) | 2009-07-17 | 2011-12-02 | Merck Sante Sas | Association d'un inhibiteur de l'echangeur sodium-proton et d'un derive amine de dihydro-1,3,5-triazine |
CA3228796A1 (en) | 2016-02-08 | 2017-08-17 | Merck Patent Gmbh | Crystalline modifications of n-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine hydrochloride and n-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine salts |
EP4230196A1 (en) | 2022-02-21 | 2023-08-23 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of dystrophinopathies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
ATE147375T1 (de) * | 1992-09-22 | 1997-01-15 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika |
EP0604852A1 (de) * | 1992-12-28 | 1994-07-06 | Hoechst Aktiengesellschaft | 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters |
DE4430916A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl-benzoylguanidin-Derivate |
-
1995
- 1995-08-11 DE DE19529612A patent/DE19529612A1/de not_active Withdrawn
-
1996
- 1996-07-16 TW TW085108613A patent/TW432039B/zh not_active IP Right Cessation
- 1996-08-02 ES ES96112498T patent/ES2206534T3/es not_active Expired - Lifetime
- 1996-08-02 AT AT96112498T patent/ATE252075T1/de active
- 1996-08-02 EP EP96112498A patent/EP0758644B1/de not_active Expired - Lifetime
- 1996-08-02 DE DE59610773T patent/DE59610773D1/de not_active Expired - Lifetime
- 1996-08-02 SI SI9630659T patent/SI0758644T1/xx unknown
- 1996-08-02 PT PT96112498T patent/PT758644E/pt unknown
- 1996-08-02 DK DK96112498T patent/DK0758644T3/da active
- 1996-08-05 CZ CZ19962312A patent/CZ292974B6/cs not_active IP Right Cessation
- 1996-08-05 AU AU61917/96A patent/AU709800B2/en not_active Expired
- 1996-08-07 SK SK1033-96A patent/SK281661B6/sk not_active IP Right Cessation
- 1996-08-08 UA UA96083195A patent/UA45965C2/uk unknown
- 1996-08-08 JP JP22459596A patent/JP3901766B2/ja not_active Expired - Lifetime
- 1996-08-08 ZA ZA9606773A patent/ZA966773B/xx unknown
- 1996-08-09 US US08/699,053 patent/US5744641A/en not_active Expired - Lifetime
- 1996-08-09 MX MX9603300A patent/MX9603300A/es unknown
- 1996-08-09 BR BRPI9603377-0A patent/BR9603377B1/pt not_active IP Right Cessation
- 1996-08-09 HU HU9602196A patent/HU226134B1/hu not_active IP Right Cessation
- 1996-08-09 CA CA002183050A patent/CA2183050C/en not_active Expired - Lifetime
- 1996-08-09 KR KR1019960033207A patent/KR100447111B1/ko not_active IP Right Cessation
- 1996-08-09 AR ARP960103933A patent/AR004677A1/es active IP Right Grant
- 1996-08-09 RU RU96115459/04A patent/RU2159232C2/ru active
- 1996-08-09 CN CN96109414A patent/CN1071743C/zh not_active Expired - Lifetime
- 1996-08-09 PL PL96315611A patent/PL184320B1/pl unknown
- 1996-08-09 NO NO963340A patent/NO306858B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR004677A1 (es) | Derivados de la 4-sulfonilbenzoilguanidina o 4-sulfinilbenzoilguanidina, procedimiento para prepararlos y composiciones farmaceuticas que los contienen | |
AR019427A1 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa, procedimiento para su preparacion, su uso para la preparacion de medicamentos, composiciones farmaceuticas y compuestos intermediarios utiles para su preparacion | |
DK282488A (da) | Farmaceutiske praeparater, deri indgaaende phenylalkylaminger eller salte deraf og forbindelsernes fremstilling | |
BR0113039A (pt) | Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto | |
ES2191048T3 (es) | Derivados de oxazolidinona y compuestos farmaceuticos que los contienen. | |
MX9308016A (es) | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. | |
BR9908325A (pt) | 6 9-dissubstituìdo 2-[trans-4(4-aminociclohexil)amino]purinas | |
DE60130023D1 (de) | Behandlung der nebenwirkungen von statinen | |
ATE158288T1 (de) | Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate | |
ES2158413T3 (es) | Alquenoilguanididas sustituidas con fenilo, procedimiento para su preparacion, su uso como farmacos o en agentes de diagnostico y medicamentos que las contienen. | |
TR200000670T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler. | |
AR002690A1 (es) | Derivado de bencimidazol o sales del mismo, composicion farmaceutica, agente inmunosupresor y agente antiinflamatorio que lo contienen yprocedimientos para preparar dicho derivado. | |
ES2255190T3 (es) | Compuestos indol 2,3-sustituidos como inhibidores de cox-2. | |
AR035434A1 (es) | Fluoralcoxifenilsulfonilureas sustituidas, procedimiento para su preparacion, procedimiento para combatir el crecimiento indeseable de las plantas o de los microorganismos, empleo de estos compuestos para combatir el crecimiento indeseable de las plantas o de los microorganismos, agente herbicida y | |
AR002273A1 (es) | Derivados de la 4-amino-benzoilguanidina, un procedimiento para prepararlos, el empleo de los mismos para preparar un medicamento, laspreparaciones farmaceuticas que las contienen y un procedimiento para preparar estas preparaciones farmaceuticas. | |
BR0313734A (pt) | Derivados do tiofeno, o seu processo de preparação e as composições farmacêuticas que os contêm | |
BR0008778A (pt) | Análogos de prostaglandinas seletivos para fpc16 insaturados | |
AR005549A1 (es) | Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos. | |
AR002954A1 (es) | Derivados de la 4-mercapto-benzoilguanidina, un procedimiento para prepararlos, empleo de los mismos para preparar un medicamento, laspreparaciones farmaceuticas que los contienen y un procedimiento para obtener estas preparaciones farmaceuticas. | |
AR008494A1 (es) | Empleo de las pirazolinonas para el tratamiento de los trastornos de la potencia, preparaciones farmaceuticas que las contienen, empleo de estaspreparaciones farmaceuticas para el tratamiento y/o la terapia de los trastornos de la potencia y un procedimiento para prepararlas | |
AR004680A1 (es) | Derivados de la alquenil-benzoilguanidina, procedimiento para prepararlos y preparaciones farmaceuticas que los contienen. | |
IS4725A (is) | Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa | |
UY27324A1 (es) | Nuevas sales de napsilato i | |
ITMI911853A1 (it) | Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono. | |
CO5271694A1 (es) | Inhibidores beta di-sustituidos de las metaloproteasas, composiciones farmaceuticas que los contienen y procedimientos para su aplicacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |